Hermann "Herm" Hasken III

Distinguished Military and Intelligence Career

Colonel Hermann G. Hasken III (Ret.) brings over three decades of elite military experience, having held leadership posts at the most sensitive and mission-critical levels of the U.S. national security apparatus. His distinguished service record includes senior command roles within the Defense Intelligence Agency (DIA), U.S. Cyber Command, and the Joint Chiefs of Staff at the Pentagon. As an intelligence officer and strategic planner, Herm led global operational initiatives spanning cyber warfare, defense intelligence integration, and multi-domain force readiness. His career earned him some of the highest honors in U.S. military service, including the Legion of Merit, the Bronze Star Medal, and the Defense Superior Service Medal, each a testament to his strategic foresight and battlefield-tested leadership.

​

Strategic Insight for Translating Innovation into Impact

Herm’s involvement with Bioramics stems from his deep commitment to national resilience and breakthrough innovation. He provides a critical bridge between the disciplined decision-making protocols of military command and the bold, pioneering innovation that defines Bioramics’ approach to drug development. With unmatched fluency in cybersecurity, mission assurance, and operational risk management, Herm supports Bioramics in building secure, scalable, and regulation-compliant infrastructures that will withstand scrutiny from both federal regulators and private-sector investors. His insight into classified operations, procurement integrity, and mission alignment enables Bioramics to navigate the biotech “Valley of Death” with confidence and precision.

​

Value to Bioramics and the Broader Mission

What sets Herm apart as a Technical Advisory Board member is not only his record of leadership but also his unique ability to guide civilian innovation ventures through the lens of national service. He advises Bioramics’ leadership on operational rigor, data protection protocols, and risk frameworks that ensure long-term sustainability. His experience working across interagency boundaries makes him an invaluable thought partner as Bioramics evaluates strategic partnerships, evaluates defense-sensitive biotechnologies, and prepares for the scrutiny that comes with FDA approvals and potential federal funding. Herm’s presence ensures Bioramics’ internal standards reflect not only world-class biotech capability but the strategic discipline of the nation’s most elite institutions.